What We're Reading: Page
Industry reads hand-picked by our editors
May 25, 2023
-
The Economist
Clinical trials are too slow and too costly—here is how to fix them
-
The Washington Post
Medical use of ketamine is surging. So are illicit forms of the drug.
-
CNN
Experimental drugs aim to surpass weight-loss stars like Ozempic and Wegovy
-
PharmaVoice
From FTC to SCOTUS, Amgen’s woes are potential ‘game changers’ for the industry
Previous
